Who owns Adaptimmune Therapeutics?

Tip: Access positions for across all investors

Analyze quarterly positions in Adaptimmune Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Adaptimmune Therapeutics stock

Who bought or sold Adaptimmune Therapeutics this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of
Matrix Capital Management Company 39M $207M 0% Mar 2021
NEA Management Company 17M $91M 0% Mar 2021
Baillie Gifford & Co 12M $61M 11% Mar 2021
Baker Bros. Advisors 9.8M $53M 55% Dec 2020
Capital World Investors 8.0M $43M 0% Mar 2021
venBio Select Advisor 3.6M $19M 0% Mar 2021
Partner Fund Management 2.7M $15M 217% Dec 2020
Citadel Advisors 2.6M $14M 31% Mar 2021
RA Capital Management 2.5M $14M -78% Dec 2020
Point72 Asset Management 2.0M $11M 13% Mar 2021
Millennium Management 1.7M $9.3M 145% Dec 2020

Setup an alert

Want to be notified whenever an investor makes a significant change to their holdings of Adaptimmune Therapeutics?

Jpmorgan Chase & Co 1.7M $0 64% Mar 2021
FMR 1.6M $8.4M 0% Mar 2021
Rock Springs Capital Management 1.5M $8.2M 0% Mar 2021
BlackRock 1.5M $7.9M 3% Mar 2021
Capital Research and Management Company - Division 3 1.3M $7.0M 0% Mar 2021
Endurant Capital Management 1.1M $5.8M 88% Dec 2020
Rafferty Asset Management 1.0M $5.5M 593% Mar 2021
Healthcare Of Ontario Pension Plan Trust Fund 458k $2.4M 100% Mar 2021
Rathbones Brothers 433k $2.3M 0% Mar 2021
State Street Corporation 408k $2.2M 13% Mar 2021
Bank of America Corporation 355k $1.9M 15022% Mar 2021
Graticule Asia Macro Advisors 347k $1.8M -28% Mar 2021
Susquehanna International 304k $1.6M -26% Mar 2021
ALPS Advisors 280k $1.5M 0% Mar 2021
CalPERS 251k $1.3M -8% Mar 2021
SG Americas Securities 235k $1.2M 100% Mar 2021
UBS Group 188k $998k 4% Mar 2021
Susquehanna Fundamental Investments 160k $848k -7% Mar 2021
QS Investors 138k $733k 100% Mar 2021
WS Management 116k $614k -5% Mar 2021
Man Group 104k $558k 40% Dec 2020
Renaissance Technologies 101k $536k -89% Mar 2021
Vontobel Holding 100k $531k 43% Mar 2021
GSA Capital Partners 93k $494k -71% Mar 2021
Henry James International Management 86k $457k 100% Mar 2021
Citigroup 86k $457k 77% Mar 2021
Mitsubishi UFJ Asset Management 77k $408k 51% Mar 2021
Virtus ETF Advisers 73k $389k 2% Mar 2021
Geode Capital Management 73k $386k 48% Mar 2021
Squarepoint Ops 56k $300k -12% Dec 2020
Goldman Sachs Group 47k $250k -8% Mar 2021
Trexquant Investment 47k $248k 100% Mar 2021
DekaBank Deutsche Girozentrale 42k $209k 0% Mar 2021
Engineers Gate Manager 39k $208k 100% Mar 2021
Vigilare Wealth Management 37k $199k 114% Mar 2021
Jane Street 35k $183k -63% Mar 2021
Simplex Trading 34k $181.652200 30% Mar 2021
Stifel Financial 34k $178k 10% Mar 2021
Janney Montgomery Scott 30k $159k 100% Mar 2021
Aperio Group 28k $149k -19% Dec 2020
ProShare Advisors 19k $100k -10% Mar 2021
Group One Trading 16k $85k 3150% Mar 2021
Hunter Associates 16k $84k 100% Mar 2021
Personal Cfo Solutions 14k $74k 17% Mar 2021
MAI Wealth Advisors 13k $67k 9% Mar 2021
Wells Fargo & Company 12k $62k 63% Mar 2021
Barclays 8.2k $43k 3% Mar 2021
KBC Group NV 6.9k $37k 77% Mar 2021
PanAgora Asset Management 6.0k $32k -16% Mar 2021
Tower Research Capital 5.7k $30k 112% Mar 2021
Geneos Wealth Management 4.5k $22k 100% Dec 2020
Cubist Systematic Strategies 4.2k $22k -81% Mar 2021
Heritage Wealth Advisors 3.3k $18k 0% Mar 2021
Penserra Capital Management 3.1k $16k -3% Mar 2021
Royal Bank of Canada 3.0k $16k 0% Mar 2021
Rockefeller Capital Management 2.0k $10k 0% Mar 2021
Hoover Financial Advisors 1.8k $8.0k 0% Mar 2021
Lindbrook Capital 1.6k $9.0k 0% Mar 2021
Us Bancorp 1.3k $4.8k -8% Mar 2021
Total Clarity Wealth Management 1.2k $6.0k 100% Mar 2021
Signature 944.00 $5.0k 321% Mar 2021
Captrust Financial Advisors 940.00 $5.0k 100% Mar 2021
Parallel Advisors 715.00 $4.0k -21% Mar 2021
Bank Of Montreal 660.00 $3.0k 100% Mar 2021
Cutler 500.00 $2.0k 0% Mar 2021
Hartland & Co 500.00 $3.0k 100% Mar 2021
NEXT Financial 475.00 $3.0k 0% Mar 2021
Daiwa Securities Group 256.00 $999.987200 0% Mar 2021
Exane Derivatives 121.00 $642.001800 0% Mar 2021
Carmichael Hill & Associates 120.00 $999.996000 0% Mar 2021

Who sold out of Adaptimmune Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Morgan Stanley Dec 2020 5.4M $29M
Lord, Abbett & Co Dec 2020 467k $2.5M
Perceptive Advisors Dec 2020 400k $2.2M
Acadian Asset Management Dec 2020 301k $1.6M
HighVista Strategies Dec 2020 159k $859k
Marshall Wace North America Sep 2020 155k $1.2M
Athanor Capital Dec 2020 97k $524k
ExodusPoint Capital Management Dec 2020 77k $415k
Northern Trust Dec 2020 50k $270k
State of Tennessee, Treasury Department Dec 2020 47k $255k
Bogle Investment Management Dec 2020 43k $229k
Jump Financial Dec 2020 40k $215k
Chicago Partners Investment Dec 2020 25k $139k
Sowell Financial Services Dec 2020 11k $61k
A.R.T. Advisors Dec 2020 10k $56k
HAP Trading Dec 2020 10k $20k
Deutsche Bank Aktiengesellschaft Dec 2020 534.00 $3.0k
Creative Financial Designs Dec 2020 400.00 $2.0k
Advisory Services Network Dec 2020 170.00 $1.0k